Novo Nordisk seeks China approval for oral Wegovy drug
Go back to Novo Nordisk seeks China approval for oral Wegovy drug| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1149.36 -10.24 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1159.60 | 52 Week High | $88.16 | |||
| Open | $1150.61 | 52 Week Low | $67.88 | |||
| Day High | $1158.44 | P/E | 266.06 | |||
| Day Low | $1138.31 | EPS | $4.32 | |||
| Volume | 2,219,855 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 46.60 -0.91 (1.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.51 | 52 Week High | $59.00 | |||
| Open | $46.35 | 52 Week Low | $32.80 | |||
| Day High | $46.74 | P/E | N/A | |||
| Day Low | $46.04 | EPS | $0.00 | |||
| Volume | 6,217,769 | |||||
